ABOUT US

WE ARE GLOBAL

AVITA Medical is a publicly listed, global regenerative medicine company that provides a novel approach to skin regeneration. Our products provide innovative treatment solutions derived from the regenerative properties of a patient’s own skin. AVITA’s proprietary technology has evidence for additional skin applications beyond treating burns, such as chronic and traumatic wounds, scar revision, and vitiligo.

CONTACT US TODAY

MANAGEMENT TEAM BOARD OF DIRECTORS

AVITA MEDICAL: INNOVATORS IN REGENERATIVE MEDICINE AROUND THE WORLD

Explore RECELL® System's approved uses and applications in your area.

EUROPE The RECELL® brands are indicated to treat burns, chronic wounds, scars, & vitiligo.* USA The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds in patients 18 years of age and older. AUSTRALIA RECELL® treats burns, acute wounds, scars, and vitiligo. CHINA RECELL® treats burns, acute wounds, scars, and vitiligo.

* In Europe, our portfolio of medical device products received CE-mark approval as three tailored product presentations, with three individual brand names. RECELL® is designed for the treatment of burns and plastic reconstructive procedures; ReGenerCell has been formulated for chronic wounds including leg and foot ulcers; and ReNovaCell is tailored for aesthetic applications including the restoration of pigmentation.

RECELL® is TGA-registered is Australia, and CFDA-cleared in China.

The RECELL® brands are indicated to treat burns, chronic wounds, scars, & vitiligo.*

RECELL® is an investigational device, limited by US Federal law to investigational use only

RECELL® treats burns, acute wounds, scars, and vitiligo

RECELL® treats burns, acute wounds, scars, and vitiligo.

* In Europe, our portfolio of medical device products received CE-mark approval as three tailored product presentations, with three individual brand names. RECELL® is designed for the treatment of burns and plastic reconstructive procedures; ReGenerCell has been formulated for chronic wounds including leg and foot ulcers; and ReNovaCell is tailored for aesthetic applications including the restoration of pigmentation.

RECELL® is TGA-registered is Australia, and CFDA-cleared in China.

WE ARE GUIDED BY PRINCIPLES.

WE ARE FOCUSED
ON PATIENT CARE

At AVITA Medical we care deeply about patients and always put them first. We aim to transform lives and improve outcomes with more effective therapies than the current standard of care.

WE ARE DRIVEN
BY INNOVATION

Being a leader in regenerative medicine means innovating with purpose. At AVITA Medical we develop novel therapeutics to treat life-altering conditions through the development of transformative therapies.

WE PUT PEOPLE FIRST

At AVITA Medical, everyone has an impact and success is achieved through respect, integrity, and accountability. We are united through our passion and dedication to improving the lives of patients through regenerative medicine.

WE DELIVER VALUE

We aim to increase corporate value and exceed shareholder expectations through the development and delivery of therapies in regenerative medicine that address unmet medical needs.

WE ARE LEADERS

WE ARE LEADERS

We deliver shareholder value through managed leadership that
has an established and impressive track record in developing,
marketing, and commercializing therapeutic products for use
throughout the world.

MEET OUR LEADERSHIP TEAM

JOIN OUR COMMUNITY

BE THE FIRST TO RECEIVE NEWS, UPDATES, AND EVENT INFORMATION FROM AVITA MEDICAL.

CONTACT US

Or Call US Customer Support
1-833-GO-AVITA

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.